A0A8C2JGN2 (A0A8C2JGN2_CYPCA) Cyprinus carpio (Common carp)

Immunoglobulin kappa constant UniProtKBProtein AtlasInterProInteractive Modelling

107 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P01834

Available Structures

66 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clade A… Heteromer
P01834; P01857; Q8JDI3;
1-107
10011×NAG;BU3;
Crystal Structure of a Broadly Neutralizing Anti-HIV-1 Antibody in Complex with a Peptide Mimotope Heteromer
P01834; P0DOX5;
1-107
99.06GOL;SO4;CXS;K;
Trastuzumab Fab v3 Heteromer
P01834; P02976; Q51918; S6B291;
1-107
100
Crystal structure of human anti-tau antibody CBTAU-27.1 Heteromer
P01834; P01857;
1-107
100GOL;
Trastuzumab Fab v3 with 5-diphenyl meditope variant Heteromer
P01834; P02976; Q51918; Q6GMX6;
1-107
100
48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID Heteromer
P01834; P01857;
1-107
100NPE;
Trastuzumab Fab v3 in complex with 5-phenyl meditope variant Heteromer
P01834; P02976; Q51918; Q6GMX6;
1-107
100
Trastuzumab Fab v3 in complex with CQFDLSTRRLKC Heteromer
P01834; P02976; Q51918; S6B291;
1-107
100
Crystal structure of a humanised 3D6 Fab bound to amyloid beta peptide Heteromer
P01834; P01857; P05067;
1-107
100
ANTIBODY GNC92H2 BOUND TO LIGAND Heteromer
P01834; P01857;
1-107
100COC;
Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade … Heteromer
P01834; P01857; Q8JDI3;
1-107
10011×NAG;
HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody… Heteromer
P01834; P04578;
1-107
99.0613×NAG;
Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 Heteromer
P01834; P55285; S6B291;
1-107
100A2G;
Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV Heteromer
A0A0M3KKW9; P01834; P01857;
1-107
100NAG;FLC;NAG;CL;
STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ) Heteromer
P01834;
1-107
100SO4;
IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER Heteromer
P01834;
1-107
100NAG;NON;
Crystal structure of NIH45-46 Fab Heteromer
P01834; P01857;
1-107
100GOL;SO4;NAG;
FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY Heteromer
P01834; P01857;
1-107
100
STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS … Heteromer
P01834; P01857;
1-107
100
Structure of P. magnus protein L bound to a human IgM Fab. Heteromer
P01834; P01871; Q51918;
1-107
100IMD;
CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 … Heteromer
P01834; P01857;
1-107
99.06NAG;NAG;
Anti-beta-amyloid antibody c706 fab in space group c2 Heteromer
P01834; P01857;
1-107
100
Structure of human B-cell antigen receptor of the IgM isotype Heteromer
P01834; P01871; P11912; P40259;
1-107
10014×NAG;
Structure of IgE bound to the ectodomain of FceRIa Heteromer
P01834; P01854; P12319;
1-107
99.06NAG;NAG;NAG;NAG;
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B Heteromer
A0A5C2G1U0; P01834; P0DP01; P0DTC2; V9HW68;
1-107
10021×NAG;NAG; 28×NAG;
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B Heteromer
A0A5C2G1U0; P01834; P0DP01; P0DTC2; V9HW68;
1-107
10022×NAG;NAG; 27×NAG;
Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex Heteromer
P01834; P04626; P0DOX5; Q6GMX6;
1-107
100NAG;NAG;
CryoEM structure of Hantavirus ANDV Gn(H) protein complex with 2Fabs ANDV-5 and ANDV-34 Heteromer
P01834; P0DOX5; Q9E006;
1-107
99.06
Crystal structure of the LT3015 antibody Fab fragment in complex with lysophosphatidic acid (14:0) Heteromer
P01834; Q6N089;
1-106
100NKN;
Crystal structure of human anti-tau antibody CBTAU-27.1 Fab in complex with a human tau peptide Heteromer
A0A2K5IAM2; P01834; P01857;
1-106
100
Crystal structure of the humanized apo LT3015 anti-lysophosphatidic acid antibody Fab fragment Heteromer
P01834; Q6N089;
1-106
100SO4;PGE;
Crystal Structure of mid-region amyloid beta capture by solanezumab Heteromer
P01834; P01857; P05067;
1-106
100
Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D Heteromer
P00746; P01834; P01857;
2-107
100
Crystal structure of the LT3015 antibody Fab fragment in complex with lysophosphatidic acid (18:2) Heteromer
P01834; Q6N089;
1-106
10018L;
IGG FAB FRAGMENT (CD25-BINDING) Heteromer
P01834;
1-106
100
Crystal structure of broadly neutralizing antibody CR8043 Heteromer
P01834; S6C4S0;
1-106
100PEG;
Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV… Heteromer
P01834; P0DOX5; P0DTC2;
1-106
100
Crystal Structure of Broadly Neutralizing Antibody CH03, Isolated from Donor CH0219, in Complex wit… Heteromer
P01834; P44815; S6BGE0; W6ICC0;
1-106
100NAG;NAG;NAG;NAG;NAG;ZN;NAG;
Crystal structure of broadly and potently neutralizing antibody VRC06B in complex with HIV-1 clade … Heteromer
P01834; P01857; Q0ED31;
1-106
100NAG;NAG;
Crystal Structure of Broadly Neutralizing Antibody CH04, Isolated from Donor CH0219, in Complex wit… Heteromer
P01834; P44815; Q4QX31;
1-106
100NAG;NAG;NAG;
BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Heteromer
P01834; Q2N0S6; Q8TCD0; S6B291;
1-106
10010×NAG; 18×NAG;NAG;NAG;NAG;NAG; 13×NAG;
AD related murine antibody Fragment Heteromer
P01647; P01808; P01834; P01857;
2-106
100
Structure of an HIV epitope scaffold in complex with neutralizing antibody b12 Fab Heteromer
P01834;
1-105
99.05GOL;
DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR Heteromer
P01834;
1-105
100
DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE Heteromer
P01834;
1-105
100CD;FRA;
Structure of cetuximab with aminoheptanoic acid-linked N-(3-hydroxypropyl)-L-arginine meditope vari… Heteromer
P01834; S6B291;
1-105
100SO4;
Structure of cetuximab with aminoheptanoic acid-linked N-(3-aminopropyl)-L-arginine meditope variant Heteromer
P01834; S6B291;
1-105
100
Structure of cetuximab with aminoheptanoic acid-linked N-carboxyethylarginine meditope variant Heteromer
P01834; S6B291;
1-105
100SO4;
Structure of cetuximab with aminoheptanoic acid-linked n-octylarginine meditope variant Heteromer
P01834; S6B291;
1-105
100SO4;
Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant Heteromer
P01834; S6B291;
1-105
100SO4;
Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated … Heteromer
P01834; Q6N089;
1-104
100
CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION Heteromer
P01834; P01857;
1-104
100CD;HOP;
UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY Heteromer
P01834; P01857;
1-104
100CD;
UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY Heteromer
P01834; P01857;
1-104
100CD;
Crystal structure of the Fab fragment of therapeutic antibody Basiliximab in complex with IL-2Ra (C… Heteromer
P01589; P01834;
1-104
100NAG;
Crystal structure of broadly neutralizing antibody CR8043 bound to H3 influenza hemagglutinin Heteromer
P01834; Q91MA7; S6C4S0;
1-104
100NAG;NAG;
Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12… Heteromer
P01834; P01857; Q2N0S6; S6B291;
1-104
10012×NAG;NAG;NAG;NAG;NAG;NAG;NAG;NAG; 18×NAG;SO4;
STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS Heteromer
P01834; P04578; S6B291;
1-103
100
Crystal structure of the NK1 domain of HGF in complex with anti-HGF monoclonal antibody SFN68. Heteromer
P01834; P14210; U3KM01;
2-101
100
Crystal structure of HLA-B*57:01.I80N Heteromer
P01834; P01889; P61769;
94-102
100
KIR3DL1 in complex with HLA-B*5701 Heteromer
P01834; P01889; P43629; P61769;
94-102
100NAG;
KIR3DL1 in complex with HLA-B*57:01.I80T Heteromer
P01834; P01889; P43629; P61769;
94-102
100NAG;
Crystal structure of HLA-B*57:01.I80N.L82R.R83G Heteromer
P01834; P01889; P61769;
94-102
100
KIR3DL1*005 in complex with HLA-B*57:01 Heteromer
P01834; P01889; P43629; P61769;
94-102
100NAG;
Crystal Structure of HLA-B*5701, presenting the self peptide, LSSPVTKSF Heteromer
P01834; P01889; P61769;
94-102
100GOL;
KIR3DL1*015 in complex with HLA-B*57:01 Heteromer
P01834; P01889; P43629; P61769;
94-102
100NAG;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8dao.1.Dmonomer0.891-106
100.00